These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 17056323

  • 1. Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease.
    Bernardo E, Angiolillo DJ, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C, Fernandez-Ortiz A.
    Am J Cardiol; 2006 Nov 01; 98(9):1182-4. PubMed ID: 17056323
    [Abstract] [Full Text] [Related]

  • 2. CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes.
    Arroyo-Espliguero R, El-Sharnouby K, Vázquez-Rey E, Kalidas K, Jeffery S, Kaski JC.
    Int J Cardiol; 2005 Feb 15; 98(2):307-12. PubMed ID: 15686783
    [Abstract] [Full Text] [Related]

  • 3. Role of the CD14 C(-260)T promoter polymorphism in determining the first clinical manifestation of coronary artery disease.
    Rizzello V, Liuzzo G, Trabetti E, Di Giannuario G, Brugaletta S, Santamaria M, Piro M, Boccanelli A, Pignatti PF, Biasucci LM, Crea F.
    J Cardiovasc Med (Hagerstown); 2010 Jan 15; 11(1):20-5. PubMed ID: 19829130
    [Abstract] [Full Text] [Related]

  • 4. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease.
    Järveläinen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO.
    Hepatology; 2001 May 15; 33(5):1148-53. PubMed ID: 11343243
    [Abstract] [Full Text] [Related]

  • 5. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease.
    Nishimura S, Zaitsu M, Hara M, Yokota G, Watanabe M, Ueda Y, Imayoshi M, Ishii E, Tasaki H, Hamasaki Y.
    J Pediatr; 2003 Sep 15; 143(3):357-62. PubMed ID: 14517520
    [Abstract] [Full Text] [Related]

  • 6. The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction.
    Longobardo MT, Cefalù AB, Pezzino F, Noto D, Emmanuele G, Barbagallo CM, Fiore B, Monastero R, Castello A, Molini V, Notarbartolo A, Travali S, Averna MR.
    Clin Exp Med; 2003 Nov 15; 3(3):161-5. PubMed ID: 14648231
    [Abstract] [Full Text] [Related]

  • 7. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK, Kim OY, Koh SJ, Jang Y, Chae JS, Kim JY, Kim HJ, Hyun YJ, Cho JR, Lee JH.
    Clin Chim Acta; 2007 May 01; 380(1-2):68-74. PubMed ID: 17335789
    [Abstract] [Full Text] [Related]

  • 8. Effects of CD14-159 C/T polymorphism on CD14 expression and the balance between proinflammatory and anti-inflammatory cytokines in whole blood culture.
    Lin J, Yao YM, Yu Y, Chai JK, Huang ZH, Dong N, Sheng ZY.
    Shock; 2007 Aug 01; 28(2):148-53. PubMed ID: 17515856
    [Abstract] [Full Text] [Related]

  • 9. Polymorphism in the promoter region of the CD14 gene and susceptibility to Brucellosis.
    Haidari M, Hajilooi M, Rezazadeh M, Rafiei A, Alavi SA, Keramat F.
    Immunol Invest; 2006 Aug 01; 35(2):239-45. PubMed ID: 16698680
    [Abstract] [Full Text] [Related]

  • 10. [Association of C1019T polymorphism in the connexin 37 gene and coronary artery disease in Chinese Han population].
    Han YL, Xi SY, Zhang XL, Yan CH, Yang Y, Kang J.
    Zhonghua Yi Xue Za Zhi; 2007 Jan 09; 87(2):100-4. PubMed ID: 17418016
    [Abstract] [Full Text] [Related]

  • 11. Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia.
    Suk Danik J, Chasman DI, Cannon CP, Miller DT, Zee RY, Kozlowski P, Kwiatkowski DJ, Ridker PM.
    Ann Hum Genet; 2006 Nov 09; 70(Pt 6):705-16. PubMed ID: 17044845
    [Abstract] [Full Text] [Related]

  • 12. Lipopolysaccharide receptor CD14 polymorphism and risk of stroke in a South-German population.
    Lichy C, Meiser H, Grond-Ginsbach C, Buggle F, Dörfer C, Grau A.
    J Neurol; 2002 Jul 09; 249(7):821-3. PubMed ID: 12140663
    [Abstract] [Full Text] [Related]

  • 13. Promoter polymorphism of the CD14 endotoxin receptor gene is associated with biliary atresia and idiopathic neonatal cholestasis.
    Shih HH, Lin TM, Chuang JH, Eng HL, Juo SH, Huang FC, Chen CL, Chen HL.
    Pediatrics; 2005 Aug 09; 116(2):437-41. PubMed ID: 16061600
    [Abstract] [Full Text] [Related]

  • 14. CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease.
    Griga T, Klein W, Epplen JT, Hebler U, Stachon A, May B.
    Hepatogastroenterology; 2005 Aug 09; 52(63):808-11. PubMed ID: 15966209
    [Abstract] [Full Text] [Related]

  • 15. Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region.
    Gilbert J, Lekstrom-Himes J, Donaldson D, Lee Y, Hu M, Xu J, Wyant T, Davidson M, MLN1202 Study Group.
    Am J Cardiol; 2011 Mar 15; 107(6):906-11. PubMed ID: 21247529
    [Abstract] [Full Text] [Related]

  • 16. The CD14 -159C-to-T promoter polymorphism in periodontal disease.
    Folwaczny M, Glas J, Török HP, Fricke K, Folwaczny C.
    J Clin Periodontol; 2004 Nov 15; 31(11):991-5. PubMed ID: 15491315
    [Abstract] [Full Text] [Related]

  • 17. Association between the promoter polymorphism T/C at position -159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease.
    Griga T, Wilkens C, Schmiegel W, Folwaczny C, Hagedorn M, Duerig N, Epplen J, Klein W.
    Eur J Med Res; 2005 May 20; 10(5):183-6. PubMed ID: 15946916
    [Abstract] [Full Text] [Related]

  • 18. CD14 gene polymorphism 159C/T in a group of patients with coronary artery disease from a population with high morbidity of cardiovascular diseases.
    Rechciński T, Grebowska A, Kurpesa M, Peruga Z, Dziuba M, Krzemińska-Pakuła M, Rudnicka W, Chmiela M.
    Kardiol Pol; 2007 Mar 20; 65(3):237-44; discussion 245. PubMed ID: 17436151
    [Abstract] [Full Text] [Related]

  • 19. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M, Inazu A, Katsuda S, Miwa K, Kawashiri MA, Nohara A, Higashikata T, Kobayashi J, Mabuchi H, Yamagishi M.
    Clin Sci (Lond); 2006 Nov 20; 111(5):325-31. PubMed ID: 16822236
    [Abstract] [Full Text] [Related]

  • 20. Influence of single-nucleotide polymorphisms on C-reactive protein levels in chronic kidney disease before and after kidney transplantation.
    Cordeiro AC, de Castro I, Pecoits-Filho R, Ramasawmy R, Rodrigues H, Borba SC, Pereira LM, Romão JE, David-Neto E, Ianhez LE, Kalil J, Abensur H.
    Transplant Proc; 2008 Dec 20; 40(10):3349-53. PubMed ID: 19100387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.